haloperidol decanoate
NDC 25021-834, haloperidol decanoate, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-834
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205241
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-834 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HALOPERIDOL DECANOATE500 mg/5mL
Pharmacologic classes
Typical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-834-05 | 25021083405 | 1 VIAL in 1 CARTON (25021-834-05) / 5 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b3167043-585f-482f-b8a7-591bc2721bd3Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-834NADAC price for package 25021083405
GET /v1/drugs/nadac/25021083405
Use it
Look up 25021-834 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-834 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-834. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.